Mechanical Thrombectomy in Patients With Cervical Artery Dissection: A Multicenter Analysis on Technical, Safety, and Functional Outcomes
Francesco Favruzzo, Marialuisa Zedde, Luca Weis, Rosario Pascarella, Alessia Giossi, Michele Besana, Francesco Valletta, Manuel Cappellari, Benedetto Petralia, Mauro Gentile, Andrea Zini, Luigi Simonetti, Stefano Vallone, Maria Giulia Mosconi, Maurizio Paciaroni, Andrea Fiacca, Aurelia Zauli, Pietro Caliandro, Iacopo Valente, Ludovica Ferraù, Paolo La Spina, Agostino Tessitore, Roberto Menozzi, Chiara Ferraro, Francesco Causin, Alessandro Pezzini, Claudio BaracchiniABSTRACT
Background and Aims
The safety and effectiveness of mechanical thrombectomy (MT) in patients with cervical artery dissection (CeAD) remain uncertain. This study aimed to evaluate the safety, recanalization rates, and functional outcomes of MT in LVO‐AIS patients with and without CeAD.
Methods
Retrospective multicenter study based on data prospectively collected from June 2021 to June 2024. CeAD‐related LVO‐AIS patients treated with MT were compared with matched anterior and posterior circulation AIS patients without CeAD. Primary outcomes included procedural adverse events, recanalization rates, and favorable functional outcomes at 3 months. A meta‐analysis of similar studies from 2015 to 2025 was conducted to support generalizability.
Results
Of 1861 LVO‐AIS patients, 164 (8.7%) patients had a CeAD. Despite a higher prevalence of tandem occlusion (63.0% vs. 20.0%, SDM: 0.99), CeAD patients showed similar rates of overall procedural adverse events (17.7% vs. 16.3%, p = 0.684), recanalization rates (90.0% vs. 87.5%, p = 0.563), and 90‐day favorable functional outcome (59.1% vs. 58.5%, p = 0.917) as compared to non‐CeAD patients. Additionally, CeAD patients had a significantly lower mortality rate at 90 days (4.3% vs. 13.1%, p = 0.023). A subgroup analysis of posterior circulation LVO‐AIS showed no significant differences in safety and clinical outcomes. Meta‐analysis of six studies suggested better MT outcomes in CEAD‐related LVO‐AIS ( p < 0.001, with I 2 = 60.02% [13.48–83.33 95% CI]).
Conclusions
Despite procedural challenges, this multicenter study has shown that in both anterior and posterior circulation CeAD‐related LVO‐AIS, MT is as safe as in non‐CeAD stroke patients, achieves high recanalization rates, and is associated with similar favorable functional outcomes.